The effects of teicoplanin (8 ,ug/ml), ampicillin (64 ,Lg/ml), imipenem (32 ,ug/ml), and gentamicin (4 ,ug/ml), alone and in combination, against 13 unique blood isolates of vancomycin-resistant (MIC for 90%o of isolates tested [MIC0], 512 ,ug/ml), teicoplanin-susceptible (MIC90, 2.0 ,ug/ml), ampicillin-resistant (MICg, 128 ,Lg/ml), and non-j-lactamase-producing Enterococcus faecium (vancomycin-resistant enterococci [VRE] isolates) were evaluated by time-kill studies. All 13 isolates exhibited high-level resistance to streptomycin; 7 isolates exhibited high-level gentamicin resistance (HLGR). After 24 h of incubation, ampicillin (64 ,ug/ml) combined with gentamicin (4 ,ug/ml) was bactericidal against three of the VRE isolates that did not display HLGR. Synergy between ampicillin and gentamicin was not observed against these isolates. Teicoplanin (8 ,ug/ml) alone was bactericidal at 24 h against five of six VRE isolates that lacked HLGR, but was not bactericidal against any HLGR VRE isolate at that time point. The addition of ampicillin (64 ,ug/ml) or imipenem (32 ,ug/ml) to teicoplanin did not significantly enhance the killing of HLGR VRE isolates as a group (P = 0.335). However, there was a trend toward improved killing of some HLGR VRE isolates by teicoplanin plus imipenem. Vancomycin (32 ,ug/ml) combined with ampicillin (64 ,ug/ml) was neither bactericidal nor synergistic against HLGR VRE isolates. Overall, bactericidal activity was attainable against 7 of 13 VRE isolates at 24 h.
Antibiotics with bactericidal activities are recommended for use in the treatment of life-threatening enterococcal infections such as endocarditis (4, 22) . Use of a synergistic combination of a cell wall-active antibiotic, such as ampicillin or vancomycin, and an aminoglycoside is usually required to attain bactericidal activity (5, 8, 17, 20, 34) . During the past 20 years, enterococcal strains with high-level resistance to each of these antibiotics have been isolated, and strains resistant to multiple antibiotics are no longer rare (10, 14, 16, 18, 23, 29) . Whether any antibiotic alone or in combination is bactericidal against enterococci resistant to multiple antibiotics is not well established. In the study described here, we evaluated the synergistic and bactericidal activities of five antibiotics alone and in combination against 13 Analysis of DNA. Total genomic DNA was prepared, digested with SmaI (Boehringer-Mannheim), and electrophoresed by using contour-clamped homogeneous electric fields as described previously (24) . Isolates were considered distinct if their pulsed-field gel electrophoresis (PFGE) patterns differed by three or more bands (32) . Medium Table 1 .
The PFGE patterns of vancomycin-resistant, ampicillinresistant E. faecium isolates (VRE isolates) that did not exhibit HLGR differed by one or two bands. HLGR VRE isolates displayed PFGE patterns that differed by one to six bands; isolates 2, 3, and 7 had similar patterns, as did isolates 5 and 6. The PFGE patterns between the two groups always differed by three or more bands (data not shown).
The data in Table 2 a Bactericidal activity is a -3-logl0 CFU/ml decrease in the original inoculum after 24 h of incubation. Synergy is a -2-loglo CFU/ml decrease obtained with the combination compared with that obtained with the more active agent used alone after 24 h of incubation; the other drug in the combination had no effect when the drug was used alone. Results are the means of at least two separate experiments. Abbreviations: C, no antibiotic; A, ampicillin (64 ,u g/ml); G, gentamicin (4 p.g/ml); T, teicoplanin (8 ,ug/ml). a Bactericidal activity is a .3-log10 CFU/ml decrease in the original inoculum after 24 h of incubation. Synergy is a .2-log10 CFU/ml decrease obtained with the combination compared with that obtained with the more active agent used alone after 24 h of incubation; the other drug of the combination had no effect when the drug was used alone. Abbreviations: C, no antibiotic; G, gentamicin (4 ,ug/ml); A, ampicillin, (64 ,ug/ml); V, vancomycin (32 ,ug/ml); T, teicoplanin (8 ,ug/ml); I, imipenem (32 ,ug/ml). (3, 6, 15, 33) . This may be true even if the isolate is moderately or highly resistant to penicillin (6, 33) . Subinhibitory concentrations of penicillin, vancomycin, and gentamicin used together were shown to be bactericidal against four of six vancomycinresistant, gentamicin-susceptible enterococcal isolates tested in time-kill studies, including two isolates with moderate-level penicillin resistance (30) . A similar antibiotics regimen was also effective in the treatment of experimental endocarditis in rabbits caused by a vancomycin-resistant, penicillin-resistant E. faecium strain (6, 7) . However, this triple antibiotic combination was not bactericidal against some vancomycin-resistant enterococci in other in vitro studies (12, 15) .
The goal of the present study was to evaluate whether bactericidal antibiotic activity against a group of 13 vancomycin-resistant, ampicillin-resistant E. faecium isolates from human blood could be demonstrated by time-kill studies. All the isolates in the present study were susceptible to teicoplanin. This antibiotic was the most effective single drug evaluated. Despite the relatively low concentration used, teicoplanin was bactericidal against five of six isolates that lacked HLGR, and caused a -2.1-loglo-unit reduction in the CFU per milliliter at VRE isolates. Although the use of ampicillin or imipenem in combination with teicoplanin had little effect overall, imipenem appeared to enhance the bactericidal effect of teicoplanin against two HLGR VRE isolates (isolates 1 and 7) at 24 h. Further evaluation of the activity of teicoplanin against VRE isolates seems warranted. However, we and others have observed that VanB enterococcal strains develop teicoplanin resistance in vitro and in vivo (1, 13) . If resistance spreads widely, the usefulness of teicoplanin in the treatment of infections caused by VanB enterococci may be limited.
Ampicillin alone was also tested against all 13 VRE isolates. After 24 h of incubation, ampicillin was not bactericidal against any isolate. Killing at 24 h was better for isolates for which ampicillin MICs were 16 or 32 ,ug/ml than for isolates for which ampicillin MICs were .64 j,g/ml (mean change in CFU per milliliter at 24 h compared with that at time zero, -1.9 and -0.2 CFU/ml, respectively; P = 0.0081). Substantial variability in killing was seen for the five isolates for which ampicillin MICs were -64 ,ug/ml, however (range, -1.7 to 1.6 CFU/ml). Knowledge of the level of ampicillin resistance may be helpful when selecting antibiotics for the treatment of enterococci resistant to multiple antibiotics.
The addition of vancomycin to ampicillin was neither synergistic nor bactericidal against any HLGR VRE isolate. These results, together with those from other investigations (9, 12) , suggest that this combination may not prove useful in the treatment of infections against which bactericidal activity is desired.
Ampicillin combined with gentamicin was tested against the VRE isolates that lacked HLGR. This combination was bactericidal against only three isolates at 24 h. Additionally, although gentamicin enhanced the killing by ampicillin, the combination was not synergistic. Other investigators have reported the absence of synergy between penicillin and gentamicin for enterococcal strains that do not display HLGR. Some E. faecalis strains with moderately high-level gentamicin resistance (MICs, 500 ,ug/ml) fail to demonstrate penicillin-gentamicin synergy (2), perhaps because of the production of an aminoglycoside-modifying enzyme (27) . Enterococcal strains for which gentamicin MICs are lower (8 or 16 jig/ml) and that did not exhibit synergy have also been described (19, 33) . Examination of one synergy-resistant E. faecalis strain for which the gentamicin MIC was 8 p,g/ml revealed that the uptake of gentamicin was not enhanced by the presence of penicillin, suggesting aberrant transport of gentamicin through the cell membrane or altered binding to the ribosomal target site (19) . In another investigation (21) , synergy between penicillin and gentamicin was not seen in time-kill assays when a starting enterococcal inoculum of 107 CFU/ml or a gentamicin concentration of 5 p,g/ml was used. Synergy was seen if the starting inoculum was lowered to 105 CFU/ml or the gentamicin concentration was increased.
Our inability to demonstrate synergy between ampicillin and gentamicin in non-HLGR VRE isolates remains unexplained. It is not related to moderately high level gentamicin resistance; the gentamicin MICs for our isolates ranged from 2 to 32 ,ug/ml. In contrast to Moellering et al. (21) , we were unable to demonstrate synergy, even though we made several modifications to the protocol of our time-kill study, including using an enriched medium, decreasing the concentration of ampicillin, and lowering the initial inoculum. The absence of synergy between ampicillin and gentamicin not associated with HLGR may be strain specific. PFGE analysis of the six isolates that we tested showed that they were closely related, indicating that they may have been derived from a single strain. Whatever the mechanism(s) for the lack of synergy between ampicillin and gentamicin against these isolates, it was not detected by screening of isolates with HLGR. Formal testing appears to be necessary to identify these strains.
In all time-kill experiments, extension of the incubation period to 48 h improved the killing of VRE isolates by one or more single antibiotics or combinations of antibiotics. Although a 48-h time point has been used in other time-kill studies (5, 33, 34) , the clinical significance of enhanced killing after prolonged incubation is not known. Until investigations of the in vivo significance of killing at 48 h are done, the 24-h time point should be relied upon to aid clinical decision making.
No antibiotic alone or in combination was bactericidal against two HLGR VRE isolates. The MICs of the antibiotics tested against the isolates were similar to the MICs for isolates for which bactericidal activity was achieved and were not predictive of a poor rate of killing. If an isolate is found to be resistant to an antibiotic with bactericidal activity, the best antibiotic or combination should be chosen on the basis of susceptibility data and clinical experience. New bactericidal antibiotics or combination of antibiotics are needed to treat serious infections caused by enterococci resistant to multiple antibiotics.
